Philips Launches Alturion AI Ultrasound System for High-Volume Care
AMSTERDAM, Netherlands, July 8, 2026 Philips announced the launch of Alturion, a next-generation AI-powered ultrasound system designed to improve...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
AMSTERDAM, Netherlands, July 8, 2026 Philips announced the launch of Alturion, a next-generation AI-powered ultrasound system designed to improve...
COLLEGE STATION, Texas, July 6, 2026 Matica Biotechnology, Inc. (Matica Bio) has entered into a strategic partnership with VaxDome...
NEW YORK, July 6, 2026 DarioHealth Corp. has announced a significant expansion of its digital health platform through a...
VALENCIA, Calif., June 29, 2026 SetPoint Medical has announced a significant milestone in the expansion of its FDA-approved SetPoint...
SYDNEY, Australia and AUCKLAND, New Zealand, June 21, 2026 Murj®, a leading provider of cardiac device management software, has...
MIAMI, June 20, 2026 INTCO Medical, a leading global manufacturer of disposable gloves and medical devices, highlighted its expanding...
SEOUL, South Korea, June 18, 2026 MediThinQ, a leading innovator in digital surgical visualization technologies, has entered into an...
PLYMOUTH MEETING, Pa., June 12, 2026 Braeburn has announced the presentation of new clinical and real-world research findings for...
SAN DIEGO, June 19, 2026 Fapon Biopharma and MOTE Therapeutics have announced plans to present their innovative dual-targeting, dual-platform...
BOSTON and ROLLE, Switzerland, June 19, 2026 SOPHiA GENETICS, a global leader in AI-driven precision medicine, has announced the...
